Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Glioma 8Multiple Myeloma 7Wilms Tumor 6Sarcoma 6Rhabdoid Tumor 6Medulloblastoma 6Rhabdomyosarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Neuroblastoma 5Lymphoma, Non-Hodgkin 5Lymphoma 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Ependymoma 5Central Nervous System Neoplasms 5Prostatic Neoplasms 4Ovarian Neoplasms 4Osteosarcoma 4Breast Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma, Ewing 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroendocrine Tumors 2Neoplasms 2Neoplasm Metastasis 2

Interventions

Rituximab 32Cyclophosphamide 28Lenalidomide 18Doxorubicin 16Prednisone 15Vincristine 14Etoposide 11CT-P10 11Gemcitabine 9polatuzumab vedotin 7Oxaliplatin 7glofitamab 6fludarabine 6acalabrutinib 6Magnetic Resonance Spectroscopy 6Ifosfamide 6Carboplatin 6tafasitamab 5prednylidene 5pembrolizumab 5ibrutinib 5deltacortene 5Specimen Handling 5R-CHOP protocol 5Nivolumab 5Biopsy 5obinutuzumab 4fludarabine phosphate 4zanubrutinib 3venetoclax 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Lymphoma, Large B-Cell, Diffuse × X-Rays × Clear all
NCT05359211 2026-03-20

NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Fred Hutchinson Cancer Center

Phase 1 Active not recruiting
27 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡